Method for demonstrating increased inactivation of pitressin in diabetes insipidus.
D001127:Arginine Vasopressin; D003919:Diabetes Insipidus / Q000502:physiology*; D020790:Diabetes Insipidus, Neurogenic; D006801:Humans; D014667:Vasopressins / Q000502:physiology*
D014667:Vasopressins; D001127:Arginine Vasopressin
DIABETES INSIPIDUS/physiology; VASOPRESSIN/physiology